Clinical trials in immunodeficiency, autoimmune diseases, and infectious diseases show that Biomodulina T restores CD3+, CD4+, and CD8+ T-cells and their function and enhances the immune response against infections (6, 12–26). This evidence concerns the gene CD4 and infection.